Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Acquisitions (2016 - 2025)

Phibro Animal Health (PAHC) has 8 years of Acquisitions data on record, last reported at -$5.3 million in Q2 2025.

  • For Q2 2025, Acquisitions changed N/A year-over-year to -$5.3 million; the TTM value through Jun 2025 reached -$4.3 million, down 261.88%, while the annual FY2025 figure was $286.5 million, 8630.32% up from the prior year.
  • Acquisitions reached -$5.3 million in Q2 2025 per PAHC's latest filing, down from $1.1 million in the prior quarter.
  • Across five years, Acquisitions topped out at $2.7 million in Q2 2022 and bottomed at -$5.3 million in Q2 2025.
  • Average Acquisitions over 3 years is -$403750.0, with a median of $504500.0 recorded in 2024.
  • The widest YoY moves for Acquisitions: up 2493.18% in 2025, down 2493.18% in 2025.
  • A 3-year view of Acquisitions shows it stood at $2.7 million in 2022, then tumbled by 101.61% to -$44000.0 in 2024, then tumbled by 12056.82% to -$5.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Acquisitions were -$5.3 million in Q2 2025, $1.1 million in Q1 2025, and -$44000.0 in Q1 2024.